Literature DB >> 14442118

Studies on the thrombolytic activity of human plasma.

W D SAWYER, A P FLETCHER, N ALKJAERSIN, S SHERRY.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN; THROMBOSIS

Mesh:

Substances:

Year:  1960        PMID: 14442118      PMCID: PMC441821          DOI: 10.1172/JCI104054

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia.

Authors:  A A COOPERBERG; G M NEIMAN
Journal:  Ann Intern Med       Date:  1955-03       Impact factor: 25.391

2.  Occurrence of fibrinolytic activity following administration of incotinic acid.

Authors:  M WEINER; W REDISCH; J M STEELE
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

3.  Studies on enhanced fibrinolytic activity in man.

Authors:  S SHERRY; R I LINDEMEYER; A P FLETCHER; N ALKJAERSIG
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

4.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

5.  Studies on the inhibition of fibrinolysis by lipids.

Authors:  H B GREIG; I A RUNDE
Journal:  Lancet       Date:  1957-09-07       Impact factor: 79.321

6.  The activation of human plasminogen. I. Spontaneous activation in glycerol.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

7.  The biological significance of fibrinolysis.

Authors:  T ASTRUP
Journal:  Lancet       Date:  1956-09-15       Impact factor: 79.321

8.  Fibrinolysis in the organism.

Authors:  T ASTRUP
Journal:  Blood       Date:  1956-09       Impact factor: 22.113

9.  Plasma fibrinolytic activity in cirrhosis of the liver.

Authors:  H C KWAAN; A J MCFADZEAN; J COOK
Journal:  Lancet       Date:  1956-01-21       Impact factor: 79.321

10.  Observations on the inactivation of fibrinolytic activity in shed blood.

Authors:  G R FEARNLEY; R REVILL; J M TWEED
Journal:  Clin Sci       Date:  1952-08       Impact factor: 6.124

View more
  22 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

3.  FIBRINOLYTIC ACTIVITY AND THYROID FUNCTION.

Authors:  R HUME
Journal:  Br Med J       Date:  1965-03-13

4.  STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.

Authors:  G P MCNICOL; A S DOUGLAS
Journal:  Br Med J       Date:  1965-05-01

5.  The clinical assessment of fibrinolysis.

Authors:  P T FLUTE
Journal:  Proc R Soc Med       Date:  1963-05

6.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

7.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

8.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

9.  Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

Authors:  S G IATRIDIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

10.  Automatic determination of euglobulin lysis time.

Authors:  J D Cash; E Leask
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.